Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the period ending July 2010. The document serves as a notification regarding a change in the scheduled announcement date for the Company's financial results for the six months ended June 30, 2010.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice and does not contain the actual financial results.
Material Changes
The primary material change disclosed is the rescheduling of the financial results announcement. The announcement was moved from Thursday, July 22, 2010, to Wednesday, July 21, 2010, at 12 noon. This change was made to avoid a conflict with other pharmaceutical companies reporting on the original date.
Guidance, Outlook, and Risks
Management commentary is limited to the rationale for the date change. The filing explicitly states that the ex-dividend date, record date, and payment date for the second quarter dividend are not affected by this schedule adjustment. No specific risks, contingencies, or unusual items are detailed in this text.
Investor Verification Checklist
- Verify the new announcement date of Wednesday, July 21, 2010, for the six-month results.
- Confirm that dividend dates remain unchanged despite the reporting schedule shift.
- Monitor the upcoming July 21 press release for actual financial performance data.